Bisphenol A promotes breast cancer cell proliferation by driving miR-381-3p-PTTG1-dependent cell cycle progression
Ping Deng(Chongqing Medical University), Zhou Zhou(Chongqing University), Yanqi Li(Shenyang Agricultural University), Mengyan Chen(Army Medical University), Miduo Tan(Central South University), Li‐Ting Wang(National Taiwan Normal University), Lei Zhang(Fudan University), Jia Xie(Army Medical University), Chunhai Chen(Army Medical University), Yu Xi(South China Normal University), Mengyu Liu(Jiangsu University), Zhengping Yu(Army Medical University), Huifeng Pi(Army Medical University), Yan Luo(AbbVie (United States)), Wei Zhou(Broad Institute), Yidan Liang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Li Tian(Army Medical University), Peng Gao(Weifang Chinese Medicine Hospital), Qinlong Ma(Army Medical University), Youlong Zeng(Army Medical University)
Cited by 57
Related Papers
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
|The Lancet Oncology|2015|1.6k
ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models
|Clinical Cancer Research|2007|776
Fluorescent probes for organelle-targeted bioactive species imaging
|Chemical Science|2019|590
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells
|Proceedings of the National Academy of Sciences|2011|256
Resistant starch intake facilitates weight loss in humans by reshaping the gut microbiota
|Nature Metabolism|2024|205